Daily Equity Report 10 OCT 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 10THOCT 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK- The market rebounded sharply after a steep fall in the last six sessions, with the Nifty50 reclaiming 11,300 levels despite waning optimism over US-China trade meeting that will be held on October 10- CLOSE PREVIOUS 11. The benchmark indices had fallen nearly 4 percent in the NIKKEI 21587.7 previous six days in a row, while BSE Smallcap index slipped 5.4 percent and Midcap index dropped 4.7 percent after rising 6-8 percent . 2021.73 ! GLOBAL FACE SECTORIAL INDICES CLOSE CHANGE (%) ! 11423.65 1.65 Asian Market- Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.39%, 9177.65 1.52 while the Nikkei 225 led the Hang Seng lower. They fell 0.61% and 0.54% respectively. 4306.50 2.00 5861.65 1.60 ! U.S. Market – North and South American markets finished broadly lower on Tuesday with shares in U.S. leading the 28785 3.67 region. The S&P 500 is down 1.56% while Mexico's IPC is off 0.97% and Brazil's Bovespa is lower by 0.59%. TOP GAINERS CLOSE CHANGE (%) ! 1,309.50 5.52 European markets- European markets are mixed. The DAX is higher by 0.84%, while the CAC 40 is leading the FTSE 100 259.20 5.34 lower. They are down 0.63% and 0.35% respectively. BHARTIARTL 359.40 5.23 SBIN 261.80 5.10 TOP LOSERS CLOSE 43.30 CHANGE (%) -5.15 YESBANK HEROMOTOC 2,599.00 -2.80 245.55 -2.37 TITAN 1,230.40 -2.27 Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY (%) 3.70 423.35 PIVOT POINTS P 11157 R1 R2 11278 675.00 4.01 10915 11036 11081 11202 11399 M&M 576.90 4.33 S1-11081 S2-11036 R1-11202 R2-11278 SBIN 261.80 5.10 (%) -0.43 ONCG -0.73 ZEEL -2.80 TCS -1.95 NET SELL (CR) FII 3517.36 DII 3286.35 NSE TOTALS BULLISH PIVOT POINTS P 28552 R1 29330 R3 30982 26122 27337 28115 29767 NIFTY BANK NIFTY S1-28115 S2-27337 R1-29330 R2-29767 1 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS Manufactured formulations manufacturing facility at SEZ, Ahmedabad. The group now has 273 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04. at the group's Cabinet hikes dearness allowance by 5%, brings cheer to employees, pensioners With the Union Cabinet clearing a proposal to hike the dearness allowance (DA) by 5% and the hiked rate will be applicable retrospectively from July this year. The move raises dearness allowance to 17% from 12% and is likely to benefit 50 lakh government employees and 62 lakh pensioners, Information and Broadcasting Minister Prakash Javadekar said while briefing media after a Union Cabinet meeting today. Dr Reddys receives EIR from USFDA for Bollaram facility ! Dr Reddys Laboratories informed the exchanges regarding the audit of its API manufacturing plant 2 at Bollaram, Hyderabad The company said that it has received the Establishment Inspection Report (EIR) from USFDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI).. ! Zydus gets USFDAs final approval for Colesevelam Hydrochloride Tablets ! Zydus Cadila has received the final approval from the USFDA to market Colesevelam Hydrochloride Tablets, (US RLD - Welchol), 625 mg. This medication is used along with a proper diet and exercise, to lower cholesterol in people with high levels of cholesterol in the blood. Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NAME OF THE STOCK : VENKEYS DATE : 10/10/2019 SEGMENT : CASH CHART TYPE : Candlestick : NSE : NSE EXCHANGE EXCHANGE TECHNICAL INDICATORS USED : VOLUME.MACD, RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY VENKEYS CASH NR CMP1643 TGT 1683 SL 1613 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Cash Intraday Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.